| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 05/09/2006 | US7041693 Antiarthritic agents; osteoporosis; antitumor agents; antiulcer agents; antiinflammatory agents |
| 05/09/2006 | US7041690 Viricides; hepatitis virus infections |
| 05/09/2006 | US7041687 Indazole compounds useful as protein kinase inhibitors |
| 05/09/2006 | US7041685 Substituted 3-aryl-5-aryl-[1,2,4]-oxadiazoles and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 05/09/2006 | US7041684 4-[2-Hydroxy-3-([4-(5-carbamoyl-2-pyridyloxy)phenyl]-2-methylpropylamino)propoxy]carbazole and salts;treating obesity; antidiabetic agent for non-insulin dependent diabetes (Type II); |
| 05/09/2006 | US7041682 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 05/09/2006 | US7041672 Substituted aryl 1, 4-pyrazine derivatives |
| 05/09/2006 | US7041669 1,4-benzofused urea compounds useful in treating cytokine mediated diseases |
| 05/09/2006 | US7041668 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 05/09/2006 | US7041235 Fluorescent diketopyrrolopyrrole analogues |
| 05/09/2006 | CA2257646C Benzo[g]quinoline derivatives |
| 05/09/2006 | CA2233666C Heterocyclic fungicides |
| 05/04/2006 | WO2006047574A1 (2-carboxamido)(3-amino) thiophene compounds |
| 05/04/2006 | WO2006047504A1 Aromatic amides as inhibitors of c-fms kinase |
| 05/04/2006 | WO2006047503A2 Inhibitors of c-fms kinase |
| 05/04/2006 | WO2006047479A2 C-fms kinase inhibitors |
| 05/04/2006 | WO2006047302A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
| 05/04/2006 | WO2006046914A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | WO2006046778A1 3-carbamoyl-2-pyridone derivative |
| 05/04/2006 | WO2006046552A1 Novel nitrogenous heterocyclic compounds and salts thereof |
| 05/04/2006 | WO2006036497A3 4-(condensed cyclicmethyl)-imidazole-2-thiones acting as alpha2 adrenergic agonists |
| 05/04/2006 | WO2006027628A3 Naphthalimide derivatives as antiviral agents |
| 05/04/2006 | WO2006023573A3 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers |
| 05/04/2006 | WO2006021454A3 Pyrimidine derivatives |
| 05/04/2006 | WO2005123692A8 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 05/04/2006 | US20060094768 Thiophene derivative ppar modulators |
| 05/04/2006 | US20060094764 Cyanothiophenes, their preparation and their use in pharmaceutical compositions |
| 05/04/2006 | US20060094739 pharmaceutical drug for treating a fungal infection; controlling and preventing plant pathogenic microorganisms in agricultural crops |
| 05/04/2006 | US20060094735 Compounds for cell proliferation, anticancer agents, kinesin inbiitors |
| 05/04/2006 | US20060094727 Inhibitors of macrophase migration inhibitory factor and methods for identifying the same |
| 05/04/2006 | US20060094720 NK1 antagonists |
| 05/04/2006 | US20060094694 Heterocyclic compounds and thrombopoietin receptor activators |
| 05/04/2006 | US20060093852 Phosphorescent and luminescent conjugated polymers and their use in electroluminescent assemblies |
| 05/04/2006 | CA2586738A1 (2-carboxamido)(3-amino) thiophene compounds |
| 05/04/2006 | CA2584409A1 Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases |
| 05/04/2006 | CA2580690A1 Bissulfonamide compounds as agonists of galr1, compositions, and methods of use |
| 05/03/2006 | EP1652841A1 Novel phenantridine analogues and their use as inhibitors of hyperproliferation of T cells and/or keratinocytes |
| 05/03/2006 | EP1651641A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651640A1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/03/2006 | EP1651637A1 3-amino chroman and 2-amino tetralin derivatives |
| 05/03/2006 | EP1651634A1 Imidazol derivatives of piperidine as histamine antagonists |
| 05/03/2006 | EP1651631A1 Bicyclic imidazol derivatives against flaviviridae |
| 05/03/2006 | EP1651629A1 Substituted benzothiophene compounds and uses thereof |
| 05/03/2006 | EP1651620A2 Piperazine derivatives and their use as therapeutic agents |
| 05/03/2006 | EP1651613A1 4,5-dihydro-imidazole as p2x7 ion channel blockers |
| 05/03/2006 | EP1651612A1 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 05/03/2006 | EP1651599A1 Tyrosine kinase inhibitors |
| 05/03/2006 | EP1651209A2 Tyrosine kinase inhibitors |
| 05/03/2006 | EP1546128B1 Pyrimidine derivatives as selective cox-2 inhibitors |
| 05/03/2006 | EP1444224B1 3-substituted oxindole beta-3 agonists |
| 05/03/2006 | EP1353904B9 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/03/2006 | EP1351954B1 Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives |
| 05/03/2006 | EP1248771B1 Method for preparing hydroxypicolinic acid derivatives |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1227805B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | EP1188755B1 Acylhydrazine derivatives, process for preparing the same and use thereof |
| 05/03/2006 | EP1153017B1 Bicyclic compounds and their use as integrin receptor ligands |
| 05/03/2006 | EP1133489B9 Isonipecotamides for the treatment of integrin-mediated disorders |
| 05/03/2006 | EP1074542B1 Sulfonamide-containing indole compounds |
| 05/03/2006 | EP0937069B1 Piperazino derivatives as neurokinin antagonists |
| 05/03/2006 | CN1768054A Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 05/03/2006 | CN1768052A Substituted pyrazole compounds |
| 05/03/2006 | CN1768051A Substituted pyrazoles |
| 05/03/2006 | CN1768050A Benzopyran compounds useful for treating inflammatory conditions |
| 05/03/2006 | CN1768049A 2-phenylpyran-4-one derivatives as selective cox-2 inhibitors |
| 05/03/2006 | CN1768043A 1,3,4-substituted pyrazoles for use as 5-ht receptor antagonists in the treatment of psychoses and neurological disorders. |
| 05/03/2006 | CN1768040A Isoquinoline-5-sulfonic acid amides as inhibitors of AKT (protein kinase B) |
| 05/03/2006 | CN1768037A Chemical compounds. |
| 05/03/2006 | CN1765887A Preparation method of imidazole aromatic alcohol analog derivative with optical activity |
| 05/03/2006 | CN1254474C Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents) |
| 05/02/2006 | US7037931 CCK-1 receptor modulators |
| 05/02/2006 | US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia |
| 05/02/2006 | US7037918 Antidiabetic agents, cardiovascular disorders, Alzheimer's disease, nervous system disorders |
| 05/02/2006 | US7037908 HIV integrase inhibitors |
| 04/27/2006 | WO2006044955A1 Phosphodiesterase 4 inhibitors |
| 04/27/2006 | WO2006044732A2 2, 6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin d2 receptor antagonists |
| 04/27/2006 | WO2006044457A1 N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 04/27/2006 | WO2006044454A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 04/27/2006 | WO2006044405A1 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | WO2006044355A1 Triazoles and their use as bradykinin b1 receptor antagonists |
| 04/27/2006 | WO2006044228A1 Histamine h3 receptor inhibitors, preparation and therapeutic uses |
| 04/27/2006 | WO2006044000A1 Sulfonamide pert-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | WO2006043691A1 Target protein and target gene in drug designing and screening method |
| 04/27/2006 | WO2006042955A1 Pyridine derivatives and the preparation and the therapeutic use thereof |
| 04/27/2006 | WO2006019957A3 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 04/27/2006 | WO2006012256A3 Fkbp binding composition and pharmaceutical use thereof |
| 04/27/2006 | WO2006000371A3 Pyrimidine derivatives as 11beta-hsd1 inhibitors |
| 04/27/2006 | WO2005090320A3 Triazole derivatives and method of using the same to treat hiv infections |
| 04/27/2006 | US20060089380 Treating nervous system disorders such as mild cognitive impairment, Alzheimer's disease or dementia associated with Down syndrome; e.g. use of 5,7-dichloro-8-hydroxy-2-(2-pyridyl)-quinoline (PBT 1052) |
| 04/27/2006 | US20060089379 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |
| 04/27/2006 | US20060089369 pyrimidine and pyridine derivatives; diabetes, neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency, cancer |
| 04/27/2006 | US20060089363 Antibacterial agents |
| 04/27/2006 | US20060089354 ligands for receptor localization studies; for inhibiting binding of vanilloid ligand to a capsaicin receptor; Phosphoric acid dibenzyl ester 4-(4-tert-butyl-phenylamino)-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-2-ylmethyl ester; to treat neuropathic pain, itch, urinary incontinence, cough, obesity |
| 04/27/2006 | CA2584422A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 04/27/2006 | CA2584328A1 Phosphodiesterase 4 inhibitors |
| 04/27/2006 | CA2583710A1 Aryl sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | CA2583667A1 Sulfonamide peri-substituted bicyclics for occlusive artery disease |
| 04/27/2006 | CA2583158A1 Triazoles and their use as bradykinin b1 receptor antagonists |
| 04/27/2006 | CA2582778A1 Pyridine derivatives and the preparation and the therapeutic use thereof |